Compared to CAR-T cells, CAR-NK cells generally produce lower levels of IL-6, a key mediator of cytokine release syndrome (CRS) toxicity, thus diminishing the risk of severe CRS (164). The gene discussed is IL6; the disease is congenital rubella syndrome.